Nanotechnology-integrated ovarian cancer metastasis therapy: Insights from the metastatic mechanisms into administration routes and therapy strategies.

Ovarian cancer is a kind of malignant tumour which locates in the pelvic cavity without typical clinical symptoms in the early stages. Most patients are diagnosed in the late stage while about 60% of them have suffered from the cancer cells spreading in the abdominal cavity. The high recurrence rate and mortality seriously damage the reproductive needs and health of women. Although recent advances in therapeutic regimes and other adjuvant therapies improved the overall survival of ovarian cancer, overcoming metastasis has still been a challenge and is necessary for achieving cure of ovarian cancer. To present potential targets and new strategies for curbing the occurrence of ovarian metastasis and the treatment of ovarian cancer after metastasis, the first section of this paper explained the metastatic mechanisms of ovarian cancer comprehensively. Nanomedicine, not limited to drug delivery, offers opportunities for metastatic ovarian cancer therapy. The second section of this paper emphasized the advantages of various administration routes of nanodrugs in metastatic ovarian cancer therapy. Furthermore, the third section of this paper focuses on advances in nanotechnology-integrated strategies for targeting metastatic ovarian cancer based on the metastatic mechanisms of ovarian cancer. Finally, the challenges and prospects of nanotherapeutics for ovarian cancer metastasis therapy were evaluated. In general, the greatest emphasis on using nanotechnology-based strategies provides avenues for improving metastatic ovarian cancer outcomes in the future.

• Publication year

  2023

• Venue

  International journal of pharmaceutics

• Publication date

  2023-03-01

• Fields of study

  Medicine, Materials Science, Engineering

• Identifiers
  DOI 10.1016/j.ijpharm.2023.122827PMID 36925023
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• HER-2-mediated nano-delivery of molecular targeted drug potently suppresses orthotopic epithelial ovarian cancer and metastasis.

  2022cited by this paper
• PCSK9 conjugated liposomes for targeted delivery of paclitaxel to the cancer cell: A proof-of-concept study.

  2022cited by this paper
• Multifunctional Human Serum Albumin Fusion Protein as a Docetaxel Nanocarrier for Chemo-photothermal Synergetic Therapy of Ovarian Cancer.

  2022cited by this paper
• Optimizing regional chemotherapy for epithelial ovarian cancer

  2022cited by this paper
• Nanoplateletsomes restrain metastatic tumor formation through decoy and active targeting in a preclinical mouse model

  2022cited by this paper
• Carrier-free multifunctional nanomedicine for intraperitoneal disseminated ovarian cancer therapy

  2022cited by this paper
• Single-Cell RNA Sequencing Reveals the Tissue Architecture in Human High-Grade Serous Ovarian Cancer

  2022cited by this paper
• Breaking the Iron Homeostasis: A “Trojan Horse” Self-Assembled Nanodrug Sensitizes Homologous Recombination Proficient Ovarian Cancer Cells to PARP Inhibition

  2022cited by this paper
• Pro‐tumoral behavior of omental adipocyte‐derived fibroblasts in tumor microenvironment at the metastatic site of ovarian cancer

  2021cited by this paper
• Aligned Collagen-CNT Nanofibrils and the Modulation Effect on Ovarian Cancer Cells

  2021cited by this paper
• Efficacy and toxicity of intraperitoneal chemotherapy as compared to intravenous chemotherapy in the treatment of patients with advanced ovarian cancer

  2021cited by this paper
• Sonosensitizer‐Functionalized Graphene Nanoribbons for Adhesion Blocking and Sonodynamic Ablation of Ovarian Cancer Spheroids

  2021cited by this paper
• Targeting metastatic cancer

  2021cited by this paper
• Low Density Lipoprotein Receptor (LDLR) and 3-Hydroxy-3-Methylglutaryl Coenzyme a Reductase (HMGCR) Expression are Associated with Platinum-Resistance and Prognosis in Ovarian Carcinoma Patients

  2021cited by this paper
• Mesothelial-to-Mesenchymal Transition and Exosomes in Peritoneal Metastasis of Ovarian Cancer

  2021cited by this paper
• Intraperitoneal Administration of a Cisplatin-Loaded Nanogel through a Hybrid System Containing an Alginic Acid-Based Nanogel and an In Situ Cross-Linkable Hydrogel for Peritoneal Dissemination of Ovarian Cancer.

  2021cited by this paper
• Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

  2021cited by this paper
• Metalloproteinases in Ovarian Cancer

  2021cited by this paper
• Targeting LRRC15 Inhibits Metastatic Dissemination of Ovarian Cancer

  2021cited by this paper
• Synergy between intraperitoneal aerosolization (PIPAC) and cancer nanomedicine: cisplatin-loaded polyarginine-hyaluronic acid nanocarriers efficiently eradicate peritoneal metastasis of advanced human ovarian cancer.

  2020cited by this paper
• Ultrabright NIR‐II Emissive Polymer Dots for Metastatic Ovarian Cancer Detection

  2020cited by this paper
• Superparamagnetic Iron Oxide Nanoparticles Induce Ferroptosis of Human Ovarian Cancer Stem Cells by Weakening Cellular Autophagy.

  2020cited by this paper
• Multiwalled carbon nanotubes inhibit cell migration and invasion by destroying actin cytoskeleton via mitochondrial dysfunction in ovarian cancer cells

  2020cited by this paper
• Constitutive activation of integrin αvβ3 contributes to anoikis resistance of ovarian cancer cells

  2020cited by this paper
• CXCL12/CXCR4 Axis-Targeted Dual-Functional Nano-Drug Delivery System Against Ovarian Cancer

  2020cited by this paper
• Novel Nanocomplexes Targeting STAT3 Demonstrate Promising Anti-Ovarian Cancer Effects in vivo

  2020cited by this paper
• Comparing Paclitaxel–Carboplatin with Paclitaxel–Cisplatin as the Front-Line Chemotherapy for Patients with FIGO IIIC Serous-Type Tubo-Ovarian Cancer

  2020cited by this paper
• Tumor microenvironment-responsive intelligent nanoplatforms for cancer theranostics

  2020cited by this paper
• Emerging nanomedicine-based strategies for preventing metastasis of pancreatic cancer.

  2020cited by this paper
• Cooperation therapy between anti-growth by photodynamic-AIEgens and anti-metastasis by small molecule inhibitors in ovarian cancer

  2020cited by this paper
• Cancer nanomedicine for combination cancer immunotherapy

  2019cited by this paper
• Doxorubicin combined with betulinic acid or lonidamine in RGD ligand-targeted pH-sensitive micellar system for ovarian cancer treatment.

  2019cited by this paper
• Layer‐by‐layer nanoparticles for novel delivery of cisplatin and PARP inhibitors for platinum‐based drug resistance therapy in ovarian cancer

  2019cited by this paper
• The basics of epithelial–mesenchymal transition (EMT): A study from a structure, dynamics, and functional perspective

  2019cited by this paper
• Regulators and mechanisms of anoikis in triple-negative breast cancer (TNBC): A review.

  2019cited by this paper
• Enhanced anti-tumor efficacy and safety with metronomic intraperitoneal chemotherapy for metastatic ovarian cancer using biodegradable nanotextile implants.

  2019cited by this paper
• Epithelial ovarian cancer: Evolution of management in the era of precision medicine

  2019cited by this paper
• Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting.

  2019cited by this paper
• p5RHH nanoparticle-mediated delivery of AXL siRNA inhibits metastasis of ovarian and uterine cancer cells in mouse xenografts

  2019cited by this paper
• Ovarian Cancer—Why Lipids Matter

  2019cited by this paper
• Real-Time Single-Walled Carbon Nanotube-Based Fluorescence Imaging Improves Survival after Debulking Surgery in an Ovarian Cancer Model.

  2019cited by this paper
• Photoacoustic Flow System for the Detection of Ovarian Circulating Tumor Cells Utilizing Copper Sulfide Nanoparticles.

  2019cited by this paper
• Randomized Trial of Intravenous Versus Intraperitoneal Chemotherapy Plus Bevacizumab in Advanced Ovarian Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study.

  2019cited by this paper
• Adding Nanotechnology to the Metastasis Treatment Arsenal.

  2019cited by this paper
• Every step of the way: integrins in cancer progression and metastasis

  2018cited by this paper
• New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer

  2018cited by this paper
• Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer

  2018cited by this paper
• Patients with BRCA mutations have superior outcomes after intraperitoneal chemotherapy in optimally resected high grade ovarian cancer.

  2018cited by this paper
• Self-Assembled Nanoparticle Mediated Survivin-T34A for Ovarian Cancer Therapy.

  2018cited by this paper
• Targeting Dependency on the GPX4 Lipid Peroxide Repair Pathway for Cancer Therapy.

  2018cited by this paper
• NIR-II nanoprobes in-vivo assembly to improve image-guided surgery for metastatic ovarian cancer

  2018cited by this paper
• Integrin αvβ6: Structure, function and role in health and disease.

  2018cited by this paper
• Intraperitoneal nanotherapy for metastatic ovarian cancer based on siRNA-mediated suppression of DJ-1 protein combined with a low dose of cisplatin.

  2018cited by this paper
• Blocking Stemness and Metastatic Properties of Ovarian Cancer Cells by Targeting p70S6K with Dendrimer Nanovector-Based siRNA Delivery.

  2018cited by this paper
• Lipid homeostasis and regulated cell death.

  2017cited by this paper
• Molecularly organic/inorganic hybrid hollow mesoporous organosilica nanocapsules with tumor-specific biodegradability and enhanced chemotherapeutic functionality.

  2017cited by this paper
• Molecular afterglow imaging with bright, biodegradable polymer nanoparticles

  2017cited by this paper
• Folate-Targeted Surface-Enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detection of Microscopic Ovarian Cancer.

  2017cited by this paper
• Slug Is Associated With Tumor Metastasis and Angiogenesis in Ovarian Cancer

  2017cited by this paper
• E-cadherin: A determinant molecule associated with ovarian cancer progression, dissemination and aggressiveness

  2017cited by this paper
• Nanoparticle delivery of siRNA against TWIST to reduce drug resistance and tumor growth in ovarian cancer models.

  2017cited by this paper
• Directed self-assembly of fluorescence responsive nanoparticles and their use for real-time surface and cellular imaging

  2017cited by this paper
• Ovarian Cancer Therapy by VSVMP Gene Mediated by a Paclitaxel-Enhanced Nanoparticle.

  2017cited by this paper
• Emerging Biological Principles of Metastasis.

  2017cited by this paper
• Intraperitoneal chemotherapy after interval debulking surgery for advanced-stage ovarian cancer: Feasibility and outcomes at a comprehensive cancer center.

  2016cited by this paper
• Metastatic colonization by circulating tumour cells

  2016cited by this paper
• Folic acid tagged nanoceria as a novel therapeutic agent in ovarian cancer

  2016cited by this paper
• A novel p70 S6 kinase-microRNA biogenesis axis mediates multicellular spheroid formation in ovarian cancer progression

  2016cited by this paper
• Cancer statistics, 2016

  2016cited by this paper
• Docetaxel combined with intraperitoneal hyperthermic perfusion chemotherapy and hyperthermia in the treatment of advanced ovarian cancer

  2016cited by this paper
• Tumor microenvironment: The culprit for ovarian cancer metastasis?

  2016cited by this paper
• Mechanistic Nanotherapeutic Approach Based on siRNA-Mediated DJ-1 Protein Suppression for Platinum-Resistant Ovarian Cancer.

  2016cited by this paper
• Hyperthermic intraperitoneal chemotherapy with paclitaxel or cisplatin in patients with stage III-C/IV ovarian cancer. Is there any difference?

  2016cited by this paper
• New models of hematogenous ovarian cancer metastasis demonstrate preferential spread to the ovary and a requirement for the ovary for abdominal dissemination.

  2016cited by this paper
• Cancer Stem Cells: Basic Concepts and Therapeutic Implications.

  2016cited by this paper
• Exosomes Promote Ovarian Cancer Cell Invasion through Transfer of CD44 to Peritoneal Mesothelial Cells

  2016cited by this paper
• Pharmacological targeting of membrane rigidity: implications on cancer cell migration and invasion

  2015cited by this paper
• Cell membrane softening in human breast and cervical cancer cells

  2015cited by this paper
• Membrane Fluidity in Cancer Cell Membranes as a Therapeutic Target: Validation using BPM 31510

  2015cited by this paper
• Receptor-Mediated Drug Delivery Systems Targeting to Glioma

  2015cited by this paper
• Whole–genome characterization of chemoresistant ovarian cancer

  2015cited by this paper
• G9a is essential for EMT-mediated metastasis and maintenance of cancer stem cell-like characters in head and neck squamous cell carcinoma

  2015cited by this paper
• Calcium and ROS: A mutual interplay

  2015cited by this paper
• Endothelium and cancer metastasis: Perspectives for antimetastatic therapy

  2015cited by this paper
• STAT3 Decoy Oligodeoxynucleotides-Loaded Solid Lipid Nanoparticles Induce Cell Death and Inhibit Invasion in Ovarian Cancer Cells

  2015cited by this paper
• TEM7 (PLXDC1), a key prognostic predictor for resectable gastric cancer, promotes cancer cell migration and invasion.

  2015cited by this paper
• Ovarian cancer: beyond resistance

  2015cited by this paper
• Pressurized intraperitoneal aerosol chemotherapy as an innovative approach to treat peritoneal carcinomatosis.

  2015cited by this paper
• DJ-1 as a human oncogene and potential therapeutic target.

  2015cited by this paper
• Motility-driven glass and jamming transitions in biological tissues.

  2015cited by this paper
• Pharmacokinetics of concomitant cisplatin and paclitaxel administered by hyperthermic intraperitoneal chemotherapy to patients with peritoneal carcinomatosis from epithelial ovarian cancer

  2014cited by this paper
• Hematogenous metastasis of ovarian cancer: rethinking mode of spread.

  2014cited by this paper
• Hypoxia and the extracellular matrix: drivers of tumour metastasis

  2014cited by this paper
• p70 S6 kinase drives ovarian cancer metastasis through multicellular spheroid-peritoneum interaction and P-cadherin/β1 integrin signaling activation

  2014cited by this paper
• Ovarian Cancer in BRCA Mutation Carriers: Improved Outcome After Intraperitoneal (IP) Cisplatin

  2014cited by this paper
• Metastatic cancer stem cells: from the concept to therapeutics.

  2014cited by this paper
• Anoikis resistance is a critical feature of highly aggressive ovarian cancer cells

  2014cited by this paper
• Active targeting using HER-2-affibody-conjugated nanoparticles enabled sensitive and specific imaging of orthotopic HER-2 positive ovarian tumors.

  2014cited by this paper
• Epithelial-mesenchymal transition enhances nanoscale actin filament dynamics of ovarian cancer cells.

  2013cited by this paper
• Targeted Nanomedicine for Suppression of CD44 and Simultaneous Cell Death Induction in Ovarian Cancer: An Optimal Delivery of siRNA and Anticancer Drug

  2013cited by this paper

• Salmonella Bacteria Membrane-Fusion Paclitaxel Loaded Liposomes for Enhanced Therapy of Intraperitoneal Metastatic Ovarian Cancer.

  2026cites this paper
• Efficacy and safety of PARP inhibitors monotherapy or combination therapy with anti-angiogenics in ovarian cancer: a network meta-analysis

  2026cites this paper
• Role of tumor microenvironment in ovarian cancer metastasis and clinical advancements

  2025cites this paper
• RNLS promotes ovarian cancer growth and inhibits ferroptosis via mediating STAT3

  2025cites this paper
• Deciphering the molecular mechanism of YY1/HIF1A modulating ovarian cancer angiogenesis based on single-cell transcriptomics technology.

  2025cites this paper
• Exploration of organoids in ovarian cancer: From basic research to clinical translation

  2024cites this paper
• Regulating Cholesterol in Tumorigenesis: A Novel Paradigm for Tumor Nanotherapeutics

  2024cites this paper
• Targeting hypoxia in combination with paclitaxel to enhance therapeutic efficacy in breast and ovarian cancer.

  2024cites this paper
• Future theranostic strategies: emerging ovarian cancer biomarkers to bridge the gap between diagnosis and treatment

  2024cites this paper
• Protein–Protein Interaction Network Construction and Differential miRNA Target Gene Prediction in Ovarian Cancer by Bioinformatics Analysis

  2024cites this paper
• Nanoparticles for the Treatment of Bone Metastasis in Breast Cancer: Recent Advances and Challenges

  2024cites this paper
• Preparation and characterization of mesoporous HA coating with paclitaxel loaded lignin nanospheres on titanium surface.

  2024cites this paper